Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
Clinical trial NCT03346135 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03346135
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-17
- Primary completion
- 2027-05-17
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.